2016, Number 2
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2016; 14 (2)
Tinea cruris in 114 patients. A study in a general hospital from 1994 to 2014
Vega-Sánchez DC, Vega-Nava CT, Arenas R
Language: Spanish
References: 11
Page: 108-111
PDF size: 149.19 Kb.
ABSTRACT
Background: tinea cruris is a superficial mycosis mainly
observed in male adults and caused by species of the genera
Trichophyton and
Epidermophyton.
Objectives: to report frequency, epidemiological and mycological
data of tinea cruris from outpatients that attended the
Dr. Manuel Gea González General Hospital, during a period of
21 years (1994-2014).
Methods: retrospective, cross-sectional and observational
study in 115 outpatients with a clinical suspicion of tinea cruris.
Results: diagnosis was confirmed by a koh exam in 114 patients.
Most frequently in males (72%) from 21 to 30 year of
age (33.91%) and less frequently in elder than 70 years of age
(3.47%), time of onset ranged from one to three weeks. Isolated
ethiological agents were
T. rubrum (40.86%) and
E. floccosum
(3.47%).
Conclusions: tinea cruris is frequently a male condition,
from 21 to 30 years of age, usually caused by
T. rubrum.
REFERENCES
Arenas, R., Micología médica ilustrada, México, McGraw Hill, 2014, p. 79.
Bonifaz, A., Micología médica básica, México, McGraw Hill, 2012, pp. 103- 104.
Arenas, R., Dermatología. Atlas, diagnóstico y tratamiento, México, Mc- Graw Hill 2015, pp. 490-491.
Arenas, R., “Dermatofitosis en México”, Rev Iberoam Micol, 2002, 19: 63-67.
Jones, T.M., Jarratt, M.T., Méndez-Moguel, I. et al., “A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged >12 years with tinea cruris”, J Drugs Dermatol, 2014, 13: 32-38.
Deepshikha, K. y Subhash, B., “Luliconazole for the treatment of fungal infections: an evidence-based review”, Core Evidence, 2014, 9: 120.
Ryder, N.S., “Terbinafine: mode of action and properties of the squalene epoxidase inhibition”, Br J Dermatol, 1992, 126: 2-7.
Del Palacio, A., Cuétara, S. y Rodríguez Noriega, A., “Topical treatment of tinea corporis and tinea cruris with eberconazole cream 1% and 2%: a phase ii dose-finding pilot study”, Mycoses, 1995, 38: 317-324.
Sanjiv, V., Choudhary, T.A. y Shazia, B., “Efficacy and safety of terbinafine hydrochloride 1% cream vs. eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris”, Indian Dermatology Online Journal, 2014, 5: 128-130.
Kane, J., Krajden, S., Summerbell, R.C. y Sibbald, R.G., “Infections caused by Trichophyton raubitschekki: clinical and epidermiological features”, Mycoses, 1990, 33: 499-506.
Gómez Moyano, E., Crespo-Erchiga, V., Samaniego González, E., Del Boz González, J. y Martínez García, S., Tinea cruris (glutealis) de importación por Trichophyton rubrum var. Raubitschekii en España”, Rev Iberoam Micol, 2008, 25: 250-253.
Full text